Tachosil Fibrin Sealant Patch

Ready-to-use Patch


Ready-to-use Packaging

Each patch is packaged individually in an appropriately sized blister pack of polystyrene-formed foil and grid varnish-coated medicinal paper and overwrapped with an aluminum laminate foil pack with a desiccant bag.

For record-keeping purposes, record patient name and TachoSil® batch number every time that TachoSil® patch is administered to a patient.

Ordering Questions

Package Sizes
TachoSil® patch is supplied in the following pack sizes:

Package with 1 patch of
3.7 in x 1.9 in (9.5 cm x 4.8 cm)
Package with 2 patches of
1.9 in x 1.9 in (4.8 cm x 4.8 cm)


  • Human fibrinogen:
    3.6 to 7.4 mg (5.5 mg)
  • Human thrombin:
    1.3 to 2.7 Units (2.0 U)
  • Other ingredients include:
    equine collagen, human albumin, riboflavin (E 101)*, sodium chloride, sodium citrate, L-arginine hydrochloride.


  • TachoSil® patch should be stored between 2°C and 25°C
  • TachoSil® patch does not require refrigeration
  • Do not freeze
  • Do not use if package is opened or damaged

* Riboflavin is included in the coating mixture as a yellow colorant to signify the active surface.

To order Tachosil Patch Call 888-229-0001To order Tachosil Patch Call 888-229-0001
To Order TachoSil® Patch Call 888-229-0001
Size Quantity
Fibrin Sealant Patch
3.7 in x 1.9 in (9.5 cm x 4.8 cm) 1 Patch
Fibrin Sealant Patch
1.9 in x 1.9 in (4.8 cm x 4.8 cm) 2 Patches

Indications and Usage

Indicated for use with manual compression in adult and pediatric patients as an adjunct to hemostasis in cardiovascular and hepatic surgery when control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical.

Not for use in place of sutures or other forms of mechanical ligation in treatment of major arterial or venous bleeding. Not for use in children under one month of age.

Selected Important Risk Information

  • TachoSil contains collagen, which may adhere to bleeding surfaces. May carry a risk of gastrointestinal obstruction in abdominal surgery due to tissue adhesions. To prevent the development of tissue adhesions at undesired sites, ensure tissue areas outside the application area are adequately cleansed before administration
  • Do not pack. Remove any unattached pieces of TachoSil® Fibrin Sealant Patch.

For more Information, please see Detailed Important Risk Information and Full Prescribing Information.